Tips, insights, and expert advice to help you manage brain and eye disease.
Our tools will help you understand and manage symptoms, treatment, and prevention of these diseases.
Doctors who prescribe Leqembi, a new FDA-approved Alzheimer’s disease drug, are required to enroll their patients in a registry to obtain Medicare insurance coverage. Here are six facts to know about patient registries, including how your privacy is protected.
Learn helpful caregiver tips for the holiday season.
Leqembi, an amyloid-clearing drug that's received full approval from the FDA, is offering renewed hope to people with early signs of dementia. Here’s what to know about it.
New research has shed light on the connection between ADHD and Alzheimer’s, including a first-of-its-kind study that suggests people who had ADHD as children may be more likely to develop Alzheimer’s as adults.
African Americans and Hispanics are at increased risk of developing glaucoma. Find out why and learn about important steps that can prevent vision loss from this eye disease.
Learn about the various forms of childhood glaucoma, as well the associated risk factors, examination procedures, and treatments.
Recent research has opened avenues to our understanding of the underlying genetics of common forms of adult-onset glaucoma. However, it is not as straightforward as a single gene mutation leading to glaucoma.
Studies have shown that taking vitamin and mineral supplements can slow the progression of age-related macular degeneration. Now, a long-term follow-up study offers the strongest findings to date that reaffirm the optimal eye vitamin supplement formula.
Anti-VEGF injections can be effective at improving wet AMD, but many patients worry about an injection in the eye. Here's what to expect before and after treatment.
If you have these vision issues, especially when waking up, you may be showing less common symptoms of macular degeneration.